A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. (Record no. 25008888)

MARC details
000 -LEADER
fixed length control field 02157 a2200553 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517040234.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201511s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1530-0293
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/CCM.0000000000001132
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Christie, Jason D
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20151104
245 00 - TITLE STATEMENT
Title A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Critical care medicine
Date of publication, distribution, etc. Sep 2015
300 ## - PHYSICAL DESCRIPTION
Extent 1859-69 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element C-Reactive Protein
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hospital Mortality
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Inflammation Mediators
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-6
General subdivision biosynthesis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-8
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridones
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Tumor Necrosis Factor, Type I
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Respiratory Distress Syndrome
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Trauma Severity Indices
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Wounds and Injuries
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element p38 Mitogen-Activated Protein Kinases
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vaslef, Steven
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chang, Philip K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name May, Addison K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gunn, Scott R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yang, Shuying
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hardes, Kelly
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kahl, Lesley
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Powley, William M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lipson, David A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bayliffe, Andrew I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lazaar, Aili L
773 0# - HOST ITEM ENTRY
Title Critical care medicine
Related parts vol. 43
-- no. 9
-- p. 1859-69
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/CCM.0000000000001132">https://doi.org/10.1097/CCM.0000000000001132</a>
Public note Available from publisher's website

No items available.